HOME Top Market Reports Microfluidics Market by Component (Microfluidic Chips, Micropump, Microneedle), Material (Polymer, Glass, Silicon), Application (Genomics, Proteomics, Capillary Electrophoresis, POC, Clinical, Environmental, Drug Delivery) - Global Forecast to 2021

Microfluidics Market by Component (Microfluidic Chips, Micropump, Microneedle), Material (Polymer, Glass, Silicon), Application (Genomics, Proteomics, Capillary Electrophoresis, POC, Clinical, Environmental, Drug Delivery) - Global Forecast to 2021

By: marketsandmarkets.com
Publishing Date: December 2016
Report Code: MD 4809

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global microfluidics market is projected to reach USD 8.78 Billion by 2021, at a CAGR of 19.2% from 2016 to 2021. The market is witnessing tremendous growth owing to the growth in the pharmaceutical and biotechnology research funding and government participation and support through funding and corporate investments, globally. However, high prices of microfluidics-based genomic and proteomic analysis platforms and lack of proper healthcare and research infrastructure in emerging markets are restraining the growth of the global market to a certain extent.

In this report, the microfluidics market is segmented on the basis of component, materials and applications. On the basis of component, the market is categorized into microfluidic chips, micropumps, microneedles, & others. On the basis of materials, the market is categorized into polymer-based microfluidics, glass-based microfluidics, silicon-based microfluidics, and other material-based microfluidics. On the basis of applications, the market is categorized into pharmaceutical research, in vitro diagnostics, and drug delivery. The pharmaceutical research application market is further divided into three major segments, namely, lab analytics (cell-based assays, proteomic analysis, genomic analysis, and capillary electrophoresis), dispensing, and microreaction. The in vitro diagnostics application segment is categorized into clinical diagnostics, point-of-care testing, environmental testing, industrial testing, and agro food testing.

North America is the largest regional segment of the global microfluidics market, followed by Europe and Asia-Pacific. The large share of this region can be attributed to growing incidence rate of various infectious diseases, availability of insurance coverage for laboratory testing procedures, sufficient reimbursements for medical devices, and presence of well-structured distribution channels in the region. In addition, an increase in the demand for self-administration and home healthcare devices, and increasing applications of micropumps, and transdermal microneedles for chronic disease areas such as migraine, diabetes, cancer pain, and asthma have boosted the growth of this market. However, the Asia-Pacific region is the fastest-growing market owing to factors such as rising geriatric population, growing per capita income, increasing investments in the healthcare industry by key market players, rising demand for advanced technologies, and expansion of private-sector hospitals to rural areas in various countries.

The global market is highly fragmented and new university startups and acquisition of small microfluidics players having high potential products is further intensifying competition. However, most of the companies are strategically aiming on developing microfluidics products in their specialized areas such as diagnostics, proteomics and genomics, and drug delivery. The high competitiveness is expected to further drive innovation in the market, thereby helping the industry to evolve and solve existing challenges.

Major players in the global microfluidics market include Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and, Becton, Dickinson and Company (U.S.)

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

Microfluidics is defined as the science of designing, fabricating, and formulating products and processes that deal with low volumes of fluids in the range of nanoliters or picoliters. The technology has evolved from MEMS (Microelectromechanical Systems) devices and can replicate all the functions of its counterparts in various healthcare applications, such as drug delivery, point-of-care (POC) testing, and clinical diagnostics.

Global Microfluidics Market

This research report categorizes the microfluidics market into the following segments:

  • Global Microfluidics Market, by Component
    • Microfluidic Chips
    • Micropumps
    • Microneedles
    • Others
  • Global Microfluidics Market, by Material
    • Polymer-based Microfluidics
    • Glass-based Microfluidics
    • Silicon-based Microfluidics
    • Other Material-based Microfluidics
  • Global Microfluidics Market, by Application
    • Pharmaceutical Research
        • Lab Analytics
          • Cell-based Assays
          • Proteomic Analysis
          • Genomic Analysis
          • Capillary Electrophoresis
        • Dispensing
        • Microreaction
    • In Vitro Diagnostics
        • Clinical Diagnostics
        • Point-of-care Testing
        • Environmental Testing
        • Industrial Testing
        • Agro Food Testing
    • Drug Delivery
  • Global Microfluidics Market, by Region
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Spain
      • Rest of Europe (RoE)
    • Asia-Pacific (APAC)
      • China
      • Japan
      • India
      • Rest of APAC
    • Rest of the World (RoW)
      • Latin America
      • Middle East and Africa

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of top companies

Geographic Analysis

  • Further breakdown of the Rest of Asia-Pacific microfluidics market into Australia, Korea, Singapore, and others
  • Further breakdown of RoW microfluidics market into in to Latin America and Middle East & Africa

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

 

Table of Contents

1 Introduction (Page No. - 18)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Periodization
    1.4 Currency and Pricing
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 22)
    2.1 Research Approach
    2.2 Microfluidics Market Size Estimation
    2.3 Data Triangulation
    2.4 Key Data From Secondary Sources
    2.5 Key Data From Primary Sources
           2.5.1 Key Industry Insights
    2.6 Assumptions for the Study

3 Executive Summary (Page No. - 29)

4 Premium Insights (Page No. - 34)
    4.1 Growth Potential of the Microfluidics Market
    4.2 Asia-Pacific Microfluidics Market, By Material
    4.3 Microfluidics Market: Geographic Growth Opportunities
    4.4 North America is Projected to Dominate the Microfluidics Market During the Forecast Period
    4.5 Microfluidics Market: Developing vs Developed Countries
    4.6 Microfluidics Market, By Application

5 Market Overview (Page No. - 39)
    5.1 Introduction
    5.2 Key Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rising Demand for Point-Of-Care (POC) Testing
                    5.2.1.2 Faster Returns on Investment
                    5.2.1.3 Faster Testing and Improved Portability Through Microfluidic Chip Miniaturization
           5.2.2 Restraints
                    5.2.2.1 Complex and Time-Consuming Regulatory Approval Process
                    5.2.2.2 Incorporation of Microfluidics Technology Into Existing Workflows
           5.2.3 Opportunities
                    5.2.3.1 Growing Asian Market
                    5.2.3.2 Expanding Applications of Drug Delivery Technologies
           5.2.4 Challenges
                    5.2.4.1 Lack of Market Visibility for Microfluidics Products
                    5.2.4.2 High Cost of Integrated Instruments and Microfluidic Sensors

6 Industry Insights (Page No. - 46)
    6.1 Introduction
    6.2 Value Chain Analysis
    6.3 Industry Trends
           6.3.1 Shifting Trend Toward Polymers Adoption
           6.3.2 Universities Actively Generating Microfluidic Start-Ups and Large Players Acquiring Small Players

7 Microfluidics Market, By Component (Page No. - 52)
    7.1 Introduction
    7.2 Microfluidic Chips
    7.3 Micropumps
    7.4 Microneedles
    7.5 Others

8 Microfluidics Market, By Material (Page No. - 60)
    8.1 Introduction
    8.2 Polymer-Based Microfluidics
    8.3 Glass-Based Microfluidics
    8.4 Silicon-Based Microfluidics
    8.5 Other Material-Based Microfluidics

9 Microfluidics Market, By Application (Page No. - 67)
    9.1 Introduction
    9.2 in Vitro Diagnostics
           9.2.1 Point-Of-Care Testing
           9.2.2 Clinical Diagnostics
           9.2.3 Agro Food Testing
           9.2.4 Industrial Testing
           9.2.5 Environmental Testing
    9.3 Pharmaceutical Research
           9.3.1 Lab Analytics
                    9.3.1.1 Proteomic Analysis
                    9.3.1.2 Genomic Analysis
                    9.3.1.3 Cell-Based Assay
                    9.3.1.4 Capillary Electrophoresis
           9.3.2 Microdispensing
           9.3.3 Microreaction
    9.4 Drug Delivery

10 Global Microfluidics Market, By Region (Page No. - 90)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 France
             10.3.3 U.K.
             10.3.4 Italy
             10.3.5 Spain
             10.3.6 Rest of Europe
     10.4 Asia-Pacific
             10.4.1 Japan
             10.4.2 China
             10.4.3 India
             10.4.4 Rest of Asia-Pacific
     10.5 Rest of the World (RoW)
             10.5.1 Latin America
             10.5.2 Middle East & Africa

11 Competitive Landscape (Page No. - 154)
     11.1 Overview
     11.2 Competitive Situations and Trends
             11.2.1 Product Launches
             11.2.2 Partnerships, Agreements, and Collaborations
             11.2.3 Acquisitions
             11.2.4 Expansions

12 Company Profiles (Page No. - 160)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     12.1 Introduction
     12.2 Danaher Corporation
     12.3 Thermo Fisher Scientific Inc.
     12.4 Perkinelmer, Inc.
     12.5 Agilent Technologies
     12.6 Bio-Rad Laboratories, Inc.
     12.7 Becton, Dickinson and Company
     12.8 F. Hoffmann-La Roche Ltd.
     12.9 Illumina, Inc.
     12.10 Raindance Technologies, Inc.
     12.11 Dolomite Microfluidics

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 190)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Other Developments
     13.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.5 Introducing RT: Real-Time Market Intelligence
     13.6 Available Customizations
     13.7 Related Reports
     13.8 Author Details


List of Tables (152 Tables)

Table 1 Impact Analysis: Microfluidics Market Drivers
Table 2 Impact Analysis: Microfluidics Market Restraints
Table 3 Impact Analysis: Microfluidics Market Opportunities
Table 4 Impact Analysis: Microfluidics Market Challenges
Table 5 List of University Startups in Microfluidics Market
Table 6 List of Acquisitions in the Microfluidics Market
Table 7 Microfluidics Market Size, By Component, 2014–2021 (USD Million)
Table 8 Microfluidic Chips Market Size, By Country/Region, 2014–2021 (USD Million)
Table 9 Micropumps Market Size, By Country, 2014–2021 (USD Million)
Table 10 Microneedles Market Size, By Country, 2014–2021 (USD Million)
Table 11 Other Microfluidic Components Market Size, By Country, 2014–2021 (USD Million)
Table 12 Microfluidics Market Size, By Material, 2014–2021 (USD Million)
Table 13 Global Polymer-Based Microfluidics Market Size, By Country/Region, 2014–2021 (USD Million)
Table 14 Global Glass-Based Microfluidics Market Size, By Country/Region, 2014–2021 (USD Million)
Table 15 Global Silicon-Based Microfluidics Market Size, By Country/Region, 2014–2021 (USD Million)
Table 16 Global Other Material-Based Microfluidics Market Size, By Country/Region, 2014–2021 (USD Million)
Table 17 Microfluidics Market Size, By Application, 2014–2021 (USD Million)
Table 18 Microfluidics Market Size Forin Vitro Diagnostics, By Type, 2014–2021 (USD Million)
Table 19 Microfluidics Market Size for in Vitro Diagnostics, By Country/Region, 2014–2021 (USD Million)
Table 20 Microfluidics Market Size for Point-Of-Care Testing, By Country/Region, 2014–2021 (USD Million)
Table 21 Microfluidics Market Size for Clinical Diagnostics, By Country/Region, 2014–2021 (USD Million)
Table 22 Microfluidics Market Size for Agro Food Testing, By Country/Region, 2014–2021 (USD Million)
Table 23 Microfluidics Market Size for Industrial Testing, By Country/Region, 2014–2021 (USD Million)
Table 24 Microfluidics Market Size for Environmental Testing, By Country/Region, 2014–2021 (USD Million)
Table 25 Microfluidics Market Size for Pharmaceutical Research By Type, 2014–2021 (USD Million)
Table 26 Microfluidics Market Size for Pharmaceutical Research, By Country/Region, 2014–2021 (USD Million)
Table 27 Microfluidics Market Size for Lab Analytics, By Type, 2014–2021 (USD Million)
Table 28 Microfluidics Market Size for Lab Analytics, By Country/Region, 2014–2021 (USD Million)
Table 29 Microfluidics Market Size for Proteomic Analysis, By Country/Region, 2014–2021 (USD Million)
Table 30 Microfluidics Market Size for Genomic Analysis, By Country/Region, 2014–2021 (USD Million)
Table 31 Microfluidics Market Size for Cell-Based Assays, By Country/Region, 2014–2021 (USD Million)
Table 32 Microfluidics Market Size for Capillary Electrophoresis, By Country/Region, 2014–2021 (USD Million)
Table 33 Microfluidics Market Size for Microdispensing, By Country/Region, 2014–2021 (USD Million)
Table 34 Microfluidic Market Size for Microreaction, By Country/Region, 2014–2021 (USD Million)
Table 35 Microfluidics Market Size for Drug Delivery, By Country/Region, 2014–2021 (USD Million)
Table 36 North America: Microfluidics Market Size, By Country, 2014–2021 (USD Million)
Table 37 North America: Microfluidics Market Size, By Component, 2014-2021 (USD Million)
Table 38 North America: Microfluidics Market Size, By Material, 2014-2021 (USD Million)
Table 39 North America: Microfluidics Market Size, By Application, 2014–2021 (USD Million)
Table 40 North America: Microfluidics Market Size for Pharmaceutical Research, By Type, 2014–2021 (USD Million)
Table 41 North America: Microfluidics Market Size for Lab Analytics, By Type, 2014–2021 (USD Million)
Table 42 North America: Microfluidics Market Size for In-Vitro Diagnostics, By Type, 2014–2021 (USD Million)
Table 43 U.S.: Microfluidics Market Size, By Component, 2014-2021 (USD Million)
Table 44 U.S.: Microfluidics Market Size, By Material, 2014–2021 (USD Million)
Table 45 U.S.: Microfluidics Market Size, By Application, 2014–2021 (USD Million)
Table 46 U.S.: Microfluidics Market Size for Pharmaceutical Research, By Type, 2014–2021 (USD Million)
Table 47 U.S.: Microfluidics Market Size for Lab Analytics, By Type, 2014–2021 (USD Million)
Table 48 U.S.: Microfluidics Market Size for In-Vitro Diagnostics, By Type, 2014–2021 (USD Million)
Table 49 Canada: Microfluidics Market Size, By Component, 2014-2021 (USD Million)
Table 50 Canada: Microfluidics Market Size, By Material, 2014-2021 (USD Million)
Table 51 Canada: Microfluidics Market Size, By Application, 2014–2021 (USD Million)
Table 52 Canada: Microfluidics Market Size for Pharmaceutical Research, By Type, 2014–2021 (USD Million)
Table 53 Canada: Microfluidics Market Size for Lab Analytics, By Type, 2014–2021 (USD Million)
Table 54 Canada: Microfluidics Market Size for In-Vitro Diagnostics, By Type, 2014–2021 (USD Million)
Table 55 Europe: Microfluidics Market Size, By Country/Region, 2014–2021 (USD Million)
Table 56 Europe: Microfluidics Market Size, By Component, 2014-2021 (USD Million)
Table 57 Europe: Microfluidics Market Size, By Material, 2014–2021 (USD Million)
Table 58 Europe: Microfluidics Market Size, By Application, 2014–2021 (USD Million)
Table 59 Europe: Microfluidics Market Size for Pharmaceutical Research, By Type, 2014–2021 (USD Million)
Table 60 Europe: Microfludics Market Size for Lab Analytics, By Type, 2014–2021 (USD Million)
Table 61 Europe: Microfludics Market Size for In-Vitro Diagnostics, By Type, 2014–2021 (USD Million)
Table 62 Germany: Microfluidics Market Size, By Component, 2014-2021 (USD Million)
Table 63 Germany: Microfluidics Market Size, By Material, 2014–2021 (USD Million)
Table 64 Germany: Microfluidics Market Size, By Application, 2014–2021 (USD Million)
Table 65 Germany: Microfludics Market Size for Pharmaceutical Research, By Type, 2014–2021 (USD Million)
Table 66 Germany: Microfludics Market Size for Lab Analytics, By Type, 2014–2021 (USD Million)
Table 67 Germany: Microfludics Market Size for In-Vitro Diagnostics, By Type, 2014–2021 (USD Million)
Table 68 France: Microfluidics Market Size, By Component, 2014-2021 (USD Million)
Table 69 France: Microfluidics Market Size, By Material, 2014–2021 (USD Million)
Table 70 France: Microfluidics Market Size, By Application, 2014–2021 (USD Million)
Table 71 France: Microfludics Market Size for Pharmaceutical Research, By Type, 2014–2021 (USD Million)
Table 72 France: Microfludics Market Size for Lab Analytics, By Type, 2014–2021 (USD Million)
Table 73 France: Microfludics Market Size for In-Vitro Diagnostics Application, By Type, 2014–2021 (USD Million)
Table 74 U.K.: Microfluidics Market Size, By Component, 2014-2021 (USD Million)
Table 75 U.K.: Microfluidics Market Size, By Material, 2014–2021 (USD Million)
Table 76 U.K.: Microfluidics Market Size, By Application, 2014–2021 (USD Million)
Table 77 U.K.: Microfluidics Market Size for Pharmaceutical Research, By Type, 2014–2021 (USD Million)
Table 78 U.K.: Microfluidics Market Size for Lab Analytics, By Type, 2014–2021 (USD Million)
Table 79 U.K.: Microfluidics Market Size for In-Vitro Diagnostics, By Type, 2014–2021 (USD Million)
Table 80 Italy: Microfluidics Market Size, By Component, 2014-2021 (USD Million)
Table 81 Italy: Microfluidics Market Size, By Material, 2014–2021 (USD Million)
Table 82 Italy: Microfluidics Market Size, By Application, 2014–2021 (USD Million)
Table 83 Italy: Microfluidics Market Size for Pharmaceutical Research, By Type, 2014–2021 (USD Million)
Table 84 Italy: Microfluidics Market Size for Lab Analytics, By Type, 2014–2021 (USD Million)
Table 85 Italy: Microfluidics Market Size for In-Vitro Diagnostics Application, By Type, 2014–2021 (USD Million)
Table 86 Spain: Microfluidics Market Size, By Component, 2014-2021 (USD Million)
Table 87 Spain: Microfluidics Market Size, By Material, 2014–2021 (USD Million)
Table 88 Spain: Microfluidics Market Size, By Application, 2014–2021 (USD Million)
Table 89 Spain: Microfluidics Market Size for Pharmaceutical Research, By Type, 2014–2021 (USD Million)
Table 90 Spain: Microfluidics Market Size for Lab Analytics, By Type, 2014–2021 (USD Million)
Table 91 Spain: Microfludics Market Size for In-Vitro Diagnostics, By Type, 2014–2021 (USD Million)
Table 92 RoE: Microfluidics Market Size, By Component, 2014-2021 (USD Million)
Table 93 RoE: Microfluidics Market Size, By Material, 2014–2021 (USD Million)
Table 94 RoE: Microfluidics Market Size, By Application, 2014–2021 (USD Million)
Table 95 RoE: Microfluidics Market Size for Pharmaceutical Research, By Type, 2014–2021 (USD Million)
Table 96 RoE: Microfluidics Market Size for Lab Analytics, By Type, 2014–2021 (USD Million)
Table 97 RoE: Microfludics Market Size for In-Vitro Diagnostics, By Type, 2014–2021 (USD Million)
Table 98 Asia-Pacific: Microfluidics Market Size, By Country/Region, 2014–2021 (USD Million)
Table 99 Asia-Pacific: Microfluidics Market Size, By Component, 2014-2021 (USD Million)
Table 100 Asia-Pacific: Microfluidics Market Size, By Material, 2014–2021 (USD Million)
Table 101 Asia-Pacific: Microfluidics Market Size, By Application, 2014–2021 (USD Million)
Table 102 Asia-Pacific: Microfluidics Market Size for Pharmaceutical Research Application, By Type, 2014–2021 (USD Million)
Table 103 Asia-Pacific: Microfluidics Market Size for Lab Analytics Application, By Type, 2014–2021 (USD Million)
Table 104 Asia-Pacific: Microfluidics Market Size for in Vitro Diagnostics Application, By Type, 2014–2021 (USD Million)
Table 105 Japan: Microfluidics Market Size, By Component, 2014-2021 (USD Million)
Table 106 Japan: Microfluidics Market Size, By Material, 2014–2021 (USD Million)
Table 107 Japan: Microfluidics Market Size, By Application, 2014–2021 (USD Million)
Table 108 Japan: Microfludics Market Size for Pharmaceutical Research Application, By Type, 2014–2021 (USD Million)
Table 109 Japan: Microfludics Market Size for Lab Analytics Application, By Type, 2014–2021 (USD Million)
Table 110 Japan: Microfludics Market Size for in Vitro Diagnostics Application, By Type, 2014–2021 (USD Million)
Table 111 China: Microfluidics Market Size, By Component, 2014-2021 (USD Million)
Table 112 China: Microfluidics Market Size, By Material, 2014–2021 (USD Million)
Table 113 China: Microfluidics Market Size, By Application, 2014–2021 (USD Million)
Table 114 China: Microfludics Market Size for Pharmaceutical Research Application, By Type, 2014–2021 (USD Million)
Table 115 China: Microfludics Market Size for Lab Analytics Application, By Type, 2014–2021 (USD Million)
Table 116 China: Microfludics Market Size for in Vitro Diagnostics Application, By Type, 2014–2021 (USD Million)
Table 117 India: Microfluidics Market Size, By Component, 2014-2021 (USD Million)
Table 118 India: Microfluidics Market Size, By Material, 2014–2021 (USD Million)
Table 119 India: Microfluidics Market Size, By Application, 2014–2021 (USD Million)
Table 120 India: Microfludics Market Size for Pharmaceutical Research Application, By Type, 2014–2021 (USD Million)
Table 121 India: Microfludics Market Size for Lab Analytics Application, By Type, 2014–2021 (USD Million)
Table 122 India: Microfludics Market Size for in Vitro Diagnostics Application, By Type, 2014–2021 (USD Million)
Table 123 Rest of Asia-Pacific: Microfluidics Market Size, By Component, 2014-2021 (USD Million)
Table 124 Rest of Asia-Pacific: Microfluidics Market Size, By Material, 2014–2021 (USD Million)
Table 125 Rest of Asia-Pacific: Microfluidics Market Size, By Application, 2014–2021 (USD Million)
Table 126 Rest of Asia-Pacific: Microfluidics Market Size for Pharmaceutical Research Application, By Type, 2014–2021 (USD Million)
Table 127 Rest of Asia-Pacific: Microfluidics Market Size for Lab Analytics Application, By Type, 2014–2021 (USD Million)
Table 128 Rest of Asia-Pacific: Microfluidics Market Size for in Vitro Diagnostics Application, By Type, 2014–2021 (USD Million)
Table 129 RoW: Microfluidics Market Size, By Region, 2014–2021 (USD Million)
Table 130 RoW: Microfluidics Market Size, By Component, 2014-2021 (USD Million)
Table 131 RoW: Microfluidics Market Size, By Material, 2014–2021 (USD Million)
Table 132 RoW: Microfluidics Market Size, By Application, 2014–2021 (USD Million)
Table 133 RoW: Microfluidics Market Size for Pharmaceutical Research Application, By Type, 2014–2021 (USD Million)
Table 134 RoW: Microfluidics Market Size for Lab Analytics Application, By Type, 2014–2021 (USD Million)
Table 135 RoW: Microfluidics Market Size for in Vitro Diagnostics Application, By Type, 2014–2021 (USD Million)
Table 136 Latin Amreica: Microfluidics Market Size, By Component, 2014-2021 (USD Million)
Table 137 Latin America: Microfluidics Market Size, By Material, 2014–2021 (USD Million)
Table 138 Latin America: Microfluidics Market Size, By Application, 2014–2021 (USD Million)
Table 139 Latin America: Microfluidics Market Size for Pharmaceutical Research Application, By Type, 2014–2021 (USD Million)
Table 140 Latin America: Microfluidics Market Size for Lab Analytics Application, By Type, 2014–2021 (USD Million)
Table 141 Latin America: Microfluidics Market Size for in Vitro Diagnostics Application, By Type, 2014–2021 (USD Million)
Table 142 Middle East & Africa: Microfluidics Market Size, By Component, 2014-2021 (USD Million)
Table 143 Middle East & Africa: Microfluidics Market Size, By Material, 2014–2021 (USD Million)
Table 144 Middle East & Africa: Microfluidics Market Size, By Application, 2014–2021 (USD Million)
Table 145 Middle East & Africa: Microfluidics Market Size for Pharmaceutical Research Application, By Type, 2014–2021 (USD Million)
Table 146 Middle East & Africa: Microfluidics Market Size for Lab Analytics Application, By Type, 2014–2021 (USD Million)
Table 147 Middle East & Africa: Microfluidics Market Size for in Vitro Diagnostics Application, By Type, 2014–2021 (USD Million)
Table 148 Growth Strategy Matrix (2013–2016)
Table 149 Product Launches, 2013–2016
Table 150 Partnerships, Agreements, and Collaborations, 2013–2016
Table 151 Acquisitions, 2013–2016
Table 152 Expansions, 2013–2016


List of Figures (41 Figures)

Figure 1 Global Microfluidics Market Segmentation
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Drug Delivery to Register Maximum Growth During the Forecast Period
Figure 8 Point-Of-Care Testing to Dominate the Global Microfluidics Market for Pharmaceutical Research Application Through 2021
Figure 9 Polymer-Based Microfluidics Estimated as the Largest Segment of the Global Microfluidics Market in 2016
Figure 10 Microfluidic Chips to Dominate the Microfluidics Market Till 2021
Figure 11 Geographic Analysis: Global Microfluidics Market
Figure 12 Rising Demand for Point-Of-Care Testing is Driving the Growth of the Global Microfluidics Market
Figure 13 Japan Accounted for the Largest Share of the Asia-Pacific Microfluidics Market, By Material, in 2015
Figure 14 The U.S. Accounted for the Largest Share of the Global Microfluidics Market in 2015
Figure 15 Microfluidics Market: Geographic Mix, 2014–2021 (USD Billion)
Figure 16 China is Projected to Register the Highest Growth During the Forecast Period
Figure 17 In Vitro Diagnostics is Expected to Dominate the Microfluidics Market Through 2021
Figure 18 Microfluidics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Value Chain Analysis
Figure 20 Microfluidics Market Players Shifting Toward Polymers Adoption
Figure 21 Microfluidic Chips Segment to Dominate the Microfluidics Market During the Forecast Period
Figure 22 Polymer-Based Microfluidics to Register Maximum Growth During the Forecast Period
Figure 23 Microfludics Market Size, By Application, 2016 vs 2021 (USD Million)
Figure 24 Point-Of-Care Testing Segment to Command the Largest Share of the in Vitro Diagnostics Market in 2016
Figure 25 Lab Analytics to Account for the Largest Share in the Global Market for Microfluidics in Pharmaceutical Research in 2016
Figure 26 Microfluidics Market Size for Lab Analytics, By Type, 2016 vs 2021 (USD Million)
Figure 27 Microfluidics Market: Geographic Snapshot (2016)
Figure 28 North America: Microfluidics Market Snapshot
Figure 29 Asia-Pacific: Microfluidics Market Snapshot
Figure 30 Product Launches Was the Key Growth Strategy Adopted By Market Players (2013 to 2016)
Figure 31 Battle for Developmental Market Share: New Product Launches Accounted for the Largest Share
Figure 32 Comparative Assessment of Key Players in the Microfluidics Market (2013–2016)
Figure 33 Geographic Revenue Mix of Top Players
Figure 34 Company Snapshot: Danaher Corporation
Figure 35 Company Snapshot: Thermo Fisher Scientific Inc.
Figure 36 Perkinelmer Inc.: Company Snapshot
Figure 37 Agilent Technologies, Inc.: Company Snapshot
Figure 38 Company Snapshot: Bio-Rad Laboratories, Inc.
Figure 39 Becton, Dickinson and Company: Company Snapshot
Figure 40 F. Hoffmann-La Roche Ltd.: Company Snapshot
Figure 41 Illumina, Inc.: Company Snapshot

The global microfluidics market is projected to reach USD 8.78 Billion by 2021from USD 3.65 Billion in 2015, at a CAGR of 19.2% during the forecast period (2016 to 2021). This market is mainly driven by the rising demand for point-of-care (POC) testing, increasing demand for microfluidic chip miniaturization as it offers lower testing time and improved portability, growing Asian market, rising incidences of lifestyle diseases, increasing R&D expenditure and healthcare spending, and growing stem cell and cancer research. However, complex and time-consuming regulatory approval process, high cost of integrated instruments and microfluidic sensors, and lack of market visibility for microfluidics products are inhibiting the growth of this market to a certain extent.

The global market is segmented on the basis of component, materials and applications. Microfluidic market by component is divided into microfluidic chips, micropumps, microneedles, & other. On the basis of materials, the market is categorized into polymer-based microfluidics, glass-based microfluidics, silicon-based microfluidics, and other material-based microfluidics. On the basis of applications, the market is divided into pharmaceutical research, in vitro diagnostics, and drug delivery. The pharmaceutical research segment is further segmented into lab analytics (cell-based assays, proteomic analysis, genomic analysis, and capillary electrophoresis), dispensing, and microreaction. The in vitro diagnostics application segment is further divided into clinical diagnostics, point-of-care testing, environmental testing, industrial testing, and agro food testing.

On the basis of regions, this market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW), which is further analyzed at country levels. The research report discusses the key market drivers, restraints, challenges, and opportunities in the global microfluidics market and its submarkets.

In 2015, the in vitro diagnostics application segment accounted for the largest share of the global microfluidics market, primarily owing to the rising incidences of chronic diseases, growing demand for point-of-care testing, and rising aging population.

Microfluidics Market

North America accounted for the largest share in 2015, followed by Europe, Asia-Pacific, and RoW. The Asia-Pacific region represents the highest-growing market for microfluidics products, primarily due to the increasing R&D and healthcare expenditure and growth in the overall healthcare industry. In addition, increasing investments in the healthcare industry by key market players, rising demand for cutting-edge technologies, and expansion of private sector hospitals to rural areas in countries such as China, Taiwan, and India are driving the growth of this region.

The microfluidics market is highly fragmented with the presence of several large and small market players. Major players in the global market are Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), Agilent Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and Becton, Dickinson and Company (U.S.).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo